The Consultant Pharmacist

IN THIS ISSUE

September 2017 | Volume 32 | Number 9

Author Interviews

Students' Perspectives on Nebulized Drugs and Nebulizer Maintenance

Potentially Inappropriate Medication Prescribing in U.S. Older Adults:

Let's Do This Together

Decisions that providers make regarding pharmacotherapy choices for older adults are often challenging.

Students’ Perspectives on Nebulized Drugs and Nebulizer Maintenance

The geriatric population requires specific considerations in using inhalation therapy, and it is recommended that the majority of geriatric patients receive respiratory therapies via a nebulizer device. If nebulizers cannot be used to deliver particular medications, then dry powdered inhalers and soft-mist inhalers are recommended over metered dose inhalers for this population.

AChE Inhibitors and NMDA Receptor Antagonists in Advanced Alzheimer’s Disease

The evidence to support a specific time frame for discontinuation of Alzheimer’s disease treatment is minimal. It is reasonable to stop a medication if there is no noticeable benefit after the first three months of treatment or once a patient’s dementia progresses to a point where there would be no meaningful benefit from continued therapy.

Potentially Inappropriate Medication Prescribing in U.S. Older Adults with Selected Chronic Conditions

Developing one or more chronic diseases increases with age. Appropriate treatment for chronic conditions often require multiple medications. The purpose of this study was to examine potentially inappropriate prescriptions in patients 65 years of age or older, seen in a primary care office, with at least one of three chronic conditions (diabetes, arthritis, depression), who were prescribed at least two medications, one of which was inappropriate for the patient’s condition.

Tamoxifen Pharmacovigilance: Implications for Safe Use in the Future

The data collected in this study imply that an absence of tamoxifen pharmacovigilance documentation is the normal standard of care. Therefore, there were many missed opportunities to provide improved patient care. Because of minimal pharmacovigilance of tamoxifen therapy, patients can be at an increased risk for developing serious complications such as thromboembolic events and uterine abnormalities.

Elias B. Chahine: Diving into Academic Pharmacy

Elias B. Chahine, PharmD, FCCP, BCPS (AQ-ID), is an associate professor of pharmacy practice at Palm Beach Atlantic University’s Lloyd L. Gregory School of Pharmacy, West Palm Beach, and a clinical pharmacy specialist at Wellington Regional Medical Center, Wellington, Florida.

2017 ASCP Forum: Policies, Politics, Partnerships Take Center Stage

Pharmacists recently gathered at a conference outside of Washington, D.C., to survey the landscape of legislative, regulatory, and technology-related issues that will impact their work now and in the future. Participants also discussed how to establish an electronic health record information exchange.

2017 ASCP Forum: Pharmacy and EHR Information Exchange: A National Summit

Cutting-edge technology that enables effective communication between settings and provides all practitioners with the information they need—when they need it—remains elusive in post-acute and  long-term care.

Can Washington Reform Health Care?

Neither party has either the will or the policy solutions to do what the public professes to want most: a health care system that consumes less than 20% of the nation’s annual economic output.

Consultant Pharmacists: The Quarterback for Vaccination Management

As consultant pharmacists know, vaccines help prevent diseases that disproportionately affect the elderly population. Vaccines not only help block conditions such as influenza, pneumonia, herpes zoster, and pertussis, but they also help save the billions of dollars these diseases cost.

READ THE JOURNAL

The Consultant Pharmacist® is the official monthly peer-reviewed journal of the American Society of Consultant Pharmacists (ASCP). It is the only journal dedicated exclusively to the medication therapy needs of seniors. ASCP members receive The Consultant Pharmacist® as a member benefit. All articles (2004 to present) are free online for members.




Nonmembers can access online abstracts to journal articles. Full articles are available for $35.00 each.


Content can be tailored and customized to fit your marketing and promotional needs and can be delivered via print or electronic format. For more information, contact:
Marcus Glover
marcus.glover@sheridan.com
800-635-7181 ext. 8065


Editorial Office
H. Edward Davidson, PharmD, MPH
Insight Therapeutics, LLC
142 W. York Street, Suite 605
Norfolk, VA 23510
757-625-6040; Fax 757-625-4538
edavidson@inther.com


Individual Subscriptions
Individuals who want to receive access to The Consultant Pharmacist but are prohibited from joining the Society, can now subscribe to the journal. Subscription options include print and online combo, print-only, and online-only.
Subscribe as an Individual

Institutions and Libraries
Libraries or other institutions may receive unlimited access to the journal both in print and online for $405 annually. Online only is available for $305 annually. Pay-per-view, individual articles ordered from the online version only, are $35 per article. Single issues of previous years are offered for sale subject to availability at $55. Subscription rates are in U.S. dollars and are subject to change.
Subscribe as an Institution

The American Society of Consultant Pharmacists (ASCP)
1321 Duke Street, Alexandria, VA 22314
© 2016-2017 ASCP | Contact Us | Privacy Policy
ASCP Foundation | BCGP